HemoClear
The Challenge
Despite its broad applicability, allogeneic (donor) red blood cell transfusion is associated with health risks, high treatment costs, and scarcity……
The Solution
Patient Blood Management (PBM) reduces the use of donor blood. Using a patient’s own [Autologous] blood for transfusion is a valuable PBM tool…….
About Us
Mission
HemoClear is a leading medical device manufacturing company that is dedicated to pursuing innovation in the development of practical and highly effective medical devices. Our mission is to offer new and reliable solutions for treating severe or life-threatening diseases.
Team
At HemoClear we work with the best and brightest people in their field in a diverse and inclusive organization where everybody contributes, irrespective of cultural, ethnic, or religious background, gender, sexual orientation, health, and age.
Vacancies
At our company, we firmly believe that a vibrant and inclusive company culture is the foundation for success. We strive to create an environment that not only values the expertise and skills of our employees but also encourages them to share their thoughts, feelings, and suggestions openly.
object(WP_Post)#13260 (24) {
["ID"]=>
int(5021)
["post_author"]=>
string(1) "2"
["post_date"]=>
string(19) "2025-10-10 14:50:10"
["post_date_gmt"]=>
string(19) "2025-10-10 14:50:10"
["post_content"]=>
string(849) "
Across rural Africa, a quiet revolution is taking place, one that’s saving lives and strengthening communities.
This short video tells a powerful story of how autologous blood transfusion is transforming maternal healthcare in low-resource settings. In areas where donor blood is scarce, HemoClear’s autologous bloodtransfusion is bridging critical gaps with a low-tech, high-impact solution.
Local healthcare teams are adopting HemoClear, proving that meaningful change is both possible and scalable.
🔴This is more than a clinical success. It’s a community impact story, and it deserves the attention of healthcare professionals and policymakers seeking sustainable solutions in under-resourced environments.
Watch the story. Share to amplify. Inspire change.
A Life-Saving Shift in Rural South Africa
Across rural Africa, a quiet revolution is taking place, one that’s saving lives and strengthening communities.
object(WP_Post)#13286 (24) {
["ID"]=>
int(5024)
["post_author"]=>
string(1) "2"
["post_date"]=>
string(19) "2025-10-10 15:22:35"
["post_date_gmt"]=>
string(19) "2025-10-10 15:22:35"
["post_content"]=>
string(877) "
HemoClear BV and Nigeria’s National Blood Service Agency (NBSA) are tackling blood scarcity with a breakthrough autologous transfusion technology, aimed at improving care for women during childbirth.
Backed by the Fund for Innovation in Development, this project turns cutting-edge solutions into action, where they’re needed most.
See how innovation is put into practice
Technology with a Mother's touch
HemoClear BV and Nigeria’s National Blood Service Agency (NBSA) are tackling blood scarcity with a breakthrough autologous transfusion technology, aimed at improving care for women during childbirth.
object(WP_Post)#13271 (24) {
["ID"]=>
int(5027)
["post_author"]=>
string(1) "2"
["post_date"]=>
string(19) "2025-10-10 15:31:26"
["post_date_gmt"]=>
string(19) "2025-10-10 15:31:26"
["post_content"]=>
string(1383) "
An analysis of 238 centrifugal cell salvage procedures (154 men, 84 women) demonstrated that quality control benchmarks were consistently achieved, reinforcing the reliability of autologous transfusion in surgical care.
Nevertheless, some variability was observed:
🔴Hematocrit targets were not met in 22% of cases
🔴Total protein elimination was insufficient in 8%
Patient-specific factors, such as age, gender, and surgical indication, had minimal impact on these outcomes.
Instead, variability was driven in nonemergency cases, by technical and procedural conditions, such as:
🔵 Low collection volumes
🔵 Excessive dilution with irrigation fluids
Anesthesiologists play a pivotal role in ensuring the quality of autologous transfusion. With real-time awareness, they adapt collection and wash parameters, even in complex or suboptimal surgical conditions, to uphold transfusion standards and protect patient outcomes.
Curious to test microfiltration technology under similar conditions, independent of centrifugal systems?
✉️ Contact us at info@https://bit.ly/419jNT1
🌐 Visit https://bit.ly/419jNT1
📑 Reference: https://bit.ly/4lPn56q
Cell Salvage process optimization drives quality
An analysis of 238 centrifugal cell salvage procedures (154 men, 84 women) demonstrated that quality control benchmarks were consistently achieved, reinforcing the reliability of autologous transfusion in surgical care.